Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

156.57 -1.44 (-0.91%)

Streaming Delayed Price Updated: 12:04 PM EST, Nov 13, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	265,707
Open	155.19
Bid (Size)	155.96 (200)
Ask (Size)	157.19 (200)
Prev. Close	158.01
Today's Range	154.47 - 157.90
52wk Range	102.97 - 182.52
Shares Outstanding	55,679,964
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

3 Cash-Producing Stocks We Approach with Caution

November 10, 2025

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Performance

YTD	+9.5%	+9.5%
1 Month	+5.3%	+5.3%
3 Month	+23.1%	+23.1%
6 Month	+22.3%	+22.3%
1 Year	+5.4%	+5.4%

More News

Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)

November 06, 2025

Via StockStory

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call

November 04, 2025

Via StockStory

3 Hyped Up Stocks with Open Questions

October 30, 2025

Via StockStory

RGEN Q3 Deep Dive: Robust Product Demand Offset by Margin Pressures and Guidance Reset

October 29, 2025

Via StockStory

Why Repligen (RGEN) Shares Are Trading Lower Today

October 28, 2025

Via StockStory

Repligen Corp (NASDAQ:RGEN) Posts Strong Q3 2025 Results, Beating Revenue and EPS Estimates ↗

October 28, 2025

Via Chartmill

Repligen’s (NASDAQ:RGEN) Q3 Sales Beat Estimates

October 28, 2025

Via StockStory

Repligen Earnings: What To Look For From RGEN

October 26, 2025

Via StockStory

3 Inflated Stocks with Questionable Fundamentals

October 21, 2025

Via StockStory

Federal Reserve Signals Further Rate Cuts Amidst Worsening Labor Market and Divided Opinions

October 14, 2025

Via MarketMinute

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

Via StockStory

Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism

October 01, 2025

Via MarketMinute

What 8 Analyst Ratings Have To Say About Repligen ↗

October 01, 2025

Via Benzinga

Why Is Repligen (RGEN) Stock Soaring Today

October 01, 2025

Via StockStory

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

September 30, 2025

Via StockStory

1 Volatile Stock to Target This Week and 2 Facing Challenges

September 25, 2025

Via StockStory

3 Reasons to Sell RGEN and 1 Stock to Buy Instead

September 24, 2025

Via StockStory

Drug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)

September 22, 2025

Via StockStory

This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗

September 22, 2025

Via Benzinga

Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway

September 19, 2025

Via MarketMinute

Repligen (RGEN) Stock Is Up, What You Need To Know

September 16, 2025

Via StockStory

Anchored at 4%: Why the Steady 10-Year Treasury Yield is Key to Unlocking the Fed's Stimulus Power

September 15, 2025

Via MarketMinute

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?

Yes, Repligen Corporation - Common Stock is publicly traded.

What exchange does Repligen Corporation - Common Stock trade on?

Repligen Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Repligen Corporation - Common Stock?

The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market

What is the current price of Repligen Corporation - Common Stock?

The current price of Repligen Corporation - Common Stock is 156.57

When was Repligen Corporation - Common Stock last traded?

The last trade of Repligen Corporation - Common Stock was at 11/13/25 12:04 PM ET

What is the market capitalization of Repligen Corporation - Common Stock?

The market capitalization of Repligen Corporation - Common Stock is 8.72B

How many shares of Repligen Corporation - Common Stock are outstanding?

Repligen Corporation - Common Stock has 9B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.